Medicare Enrolled
Dr. Ananth Iyer, MD
Hematology · St Petersburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Iyer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iyer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iyer
Dr. Ananth Iyer is a hematology specialist in St Petersburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Iyer performed 42,359 Medicare services across 1,285 unique beneficiaries.
Between the years covered by Open Payments, Dr. Iyer received a total of $15,509 from 90 pharmaceutical and/or device companies across 744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iyer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 42,359 Medicare services
$15,509 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,359
Medicare services
Bottom 33% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,285
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,118 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 22,440 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 8,440 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 4,680 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 1,380 | $19 | $51 |
| Blood draw (venipuncture) | 961 | $8 | $9 |
| Complete blood count (CBC) with differential | 945 | $8 | $29 |
| Dexamethasone injection (steroid) | 910 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 550 | $1 | $28 |
| Office visit, established patient (30-39 min) | 467 | $95 | $339 |
| Drug injection, under skin or into muscle | 429 | $11 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 206 | $96 | $378 |
| Injection of additional new drug or substance into vein | 199 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 77 | $46 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 74 | $21 | $84 |
| Red blood count, automated test | 65 | $4 | $10 |
| Administration of additional new drug or substance into vein, 1 hour or less | 63 | $49 | $178 |
| Office visit, established patient, complex (40-54 min) | 63 | $136 | $474 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 62 | $17 | $59 |
| Hospital follow-up visit, moderate complexity | 62 | $63 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 54 | $3 | $11 |
| Injection, diphenhydramine hcl, up to 50 mg | 50 | $1 | $3 |
| Initial hospital admission, high complexity | 41 | $137 | $556 |
| Injection of drug or substance into vein | 39 | $27 | $156 |
| New patient office visit, complex (60-74 min) | 34 | $172 | $585 |
| Infusion, normal saline solution , 1000 cc | 30 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 26 | $25 | $156 |
| New patient office visit (45-59 min) | 12 | $131 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.5% high complexity
40.0% medium
6.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,509
Total received (2018-2024)
Avg $2,216/year across 7 years
Top 32% in FL for hematology
90
Companies
744
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,195 (91.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$662 (4.3%)
Other
Charitable contributions, space rental, and other categories
$652 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,788
2023
$4,028
2022
$2,777
2021
$69
2020
$509
2019
$2,258
2018
$2,080
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,846
E.R. Squibb & Sons, L.L.C.
$947
AstraZeneca Pharmaceuticals LP
$805
Daiichi Sankyo Inc.
$619
Janssen Biotech, Inc.
$604
PFIZER INC.
$591
Amgen Inc.
$576
Lilly USA, LLC
$553
Genentech USA, Inc.
$529
Merck Sharp & Dohme LLC
$494
GENZYME CORPORATION
$437
Astellas Pharma US Inc
$433
Merck Sharp & Dohme Corporation
$409
Celgene Corporation
$387
Incyte Corporation
$341
Gilead Sciences, Inc.
$338
Regeneron Healthcare Solutions, Inc.
$338
Takeda Pharmaceuticals U.S.A., Inc.
$334
NOVARTIS PHARMACEUTICALS CORPORATION
$321
Seagen Inc.
$275
SOBI, INC
$208
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
Eisai Inc.
$187
Exelixis Inc.
$152
ARRAY BIOPHARMA INC
$148
Pharmacyclics LLC, An AbbVie Company
$140
GlaxoSmithKline, LLC.
$138
Blueprint Medicines Corporation
$131
Seattle Genetics, Inc.
$128
Bayer HealthCare Pharmaceuticals Inc.
$125
JAZZ PHARMACEUTICALS INC.
$117
TerSera Therapeutics LLC
$113
BeiGene USA, Inc.
$111
Rigel Pharmaceuticals, Inc.
$105
PUMA BIOTECHNOLOGY, INC.
$97
Foundation Medicine, Inc.
$96
Pharmacosmos Therapeutics Inc.
$90
PharmaEssentia USA Corporation
$88
Puma Biotechnology, Inc.
$87
Kite Pharma, Inc.
$85
ABBVIE INC.
$81
EISAI INC.
$76
TAIHO ONCOLOGY, INC.
$73
Sun Pharmaceutical Industries Inc.
$67
AVEO Pharmaceuticals, Inc.
$62
Sumitomo Pharma America, Inc.
$61
Aveo Pharmaceuticals, Inc.
$61
G1 Therapeutics, Inc.
$61
AMAG Pharmaceuticals, Inc.
$58
Jazz Pharmaceuticals Inc.
$57
Mirati Therapeutics, Inc.
$56
EMD Serono, Inc.
$55
Alexion Pharmaceuticals, Inc.
$55
Stemline Therapeutics Inc.
$46
Agios Pharmaceuticals, Inc.
$44
Karyopharm Therapeutics Inc.
$42
CTI BioPharma Corp.
$42
Clovis Oncology, Inc.
$41
MorphoSys, US Inc.
$39
Partner Therapeutics, Inc.
$39
Array BioPharma Inc.
$39
Janssen Pharmaceuticals, Inc
$38
Acrotech Biopharma Inc.
$35
Helsinn Therapeutics (U.S.), Inc.
$34
MEDIVATION FIELD SOLUTIONS LLC
$32
Ipsen Biopharmaceuticals, Inc
$30
Adaptive Biotechnologies Corporation
$29
Legend Biotech USA Inc.
$29
Geron Corporation
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Advanced Accelerator Applications
$21
Heron Therapeutics, Inc.
$20
GE HealthCare
$19
SANOFI-AVENTIS U.S. LLC
$19
Myovant Sciences Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Mylan Pharmaceuticals Inc.
$19
Tempus AI, Inc
$18
Organon LLC
$18
Lexicon Pharmaceuticals, Inc.
$18
Taiho Oncology, Inc.
$18
EUSA Pharma (US) LLC
$17
Acrotech Biopharma LLC
$15
Kyowa Kirin, Inc.
$14
PROGENICS PHARMACEUTICALS, INC.
$14
Secura Bio, Inc.
$13
Progenics Pharmaceuticals, Inc.
$13
Dova Pharmaceuticals
$12
Top 3 companies account for 23.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · ENHERTU · ERLEADA · EXKIVITY · Enhertu · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Gazyva · HYQVIA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TEVIMBRA · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $37 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
37
Per 100K population
3.9
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Iyer is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Iyer experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Iyer performed 22,440 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iyer receive payments from pharmaceutical companies?
Yes. Dr. Iyer received a total of $15,509 from 90 companies across 744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iyer's costs compare to other hematologists in St Petersburg?
Dr. Iyer's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iyer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in St Petersburg
Browse hematologists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology